Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives $36.40 Average Target Price from Analysts
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Get Free Report) has received an average rating of “Hold” from the five brokerages that are covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 1 year price objective among analysts […]
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Get Free Report) has received an average rating of “Hold” from the five brokerages that are covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 1 year price objective among analysts […]
